Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin G Sanda

Showing results (121-130 of 180) with videos related to

Pageof 18
Sort By:
Human Pathology|August 17, 2014
Prostate cancer with Paneth cell-like neuroendocrine differentiation has recognizable histomorphology and harbors AURKA gene amplificationKyung Park, Zhengming Chen, Theresa Y MacDonald, et al.
Cancer Research|February 12, 2004
The role of metastasis-associated protein 1 in prostate cancer progressionMatthias D Hofer, Rainer Kuefer, Sooryanarayana Varambally, et al.
BJU International|January 21, 2017
Evaluation of a 24-gene signature for prognosis of metastatic events and prostate cancer-specific mortalityKathryn L Pellegrini, Martin G Sanda, Dattatraya Patil, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2017
Gleason Score 7 Prostate Cancers Emerge through Branched Evolution of Clonal Gleason Pattern 3 and 4Adam G Sowalsky, Haydn T Kissick, Sean J Gerrin, et al.
Urologic Oncology|May 24, 2011
Combining urinary detection of TMPRSS2:ERG and PCA3 with serum PSA to predict diagnosis of prostate cancerSimpa S Salami, Folke Schmidt, Bharathi Laxman, et al.
Urology|October 22, 2013
Neoadjuvant androgen deprivation therapy leads to immediate impairment of vitality/hormonal and sexual quality of life: results of a multicenter prospective studyHiram Alberto Gay, Jeff M Michalski, Daniel A Hamstra, et al.
JCO Precision Oncology|August 20, 2025
Sociodemographic Features, Health Care Costs, and Treatment Implications of Genomic Classifier Testing for Localized Prostate Cancer in the United StatesJames R Janopaul-Naylor, Dattatraya Patil, Shreyas Joshi, et al.
Cancers|December 9, 2023
Integrated Genomic Analysis of Primary Prostate Tumor Foci and Corresponding Lymph Node Metastases Identifies Mutations and Pathways Associated with MetastasisCarlos S Moreno, Cynthia L Winham, Mehrdad Alemozaffar, et al.
Cancer Biomarkers : Section a of Disease Markers|March 20, 2025
A simplified MyProstateScore2.0 for high-grade prostate cancerTiffany M Tang, Yuping Zhang, Ana M Kenney, et al.
Urology|March 12, 2026
Patient-reported psychological and prostate cancer-specific functional outcomes among men with low-risk prostate cancer two years after diagnosis: The PREPARE prospective cohort studyKimberly M Davis, George Luta, Richard M Hoffman, et al.
Pageof 18

Showing results (121-130 of 180) with videos related to

Sort By:
Pageof 18
Human Pathology|August 17, 2014
Prostate cancer with Paneth cell-like neuroendocrine differentiation has recognizable histomorphology and harbors AURKA gene amplificationKyung Park, Zhengming Chen, Theresa Y MacDonald, et al.
Cancer Research|February 12, 2004
The role of metastasis-associated protein 1 in prostate cancer progressionMatthias D Hofer, Rainer Kuefer, Sooryanarayana Varambally, et al.
BJU International|January 21, 2017
Evaluation of a 24-gene signature for prognosis of metastatic events and prostate cancer-specific mortalityKathryn L Pellegrini, Martin G Sanda, Dattatraya Patil, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2017
Gleason Score 7 Prostate Cancers Emerge through Branched Evolution of Clonal Gleason Pattern 3 and 4Adam G Sowalsky, Haydn T Kissick, Sean J Gerrin, et al.
Urologic Oncology|May 24, 2011
Combining urinary detection of TMPRSS2:ERG and PCA3 with serum PSA to predict diagnosis of prostate cancerSimpa S Salami, Folke Schmidt, Bharathi Laxman, et al.
Urology|October 22, 2013
Neoadjuvant androgen deprivation therapy leads to immediate impairment of vitality/hormonal and sexual quality of life: results of a multicenter prospective studyHiram Alberto Gay, Jeff M Michalski, Daniel A Hamstra, et al.
JCO Precision Oncology|August 20, 2025
Sociodemographic Features, Health Care Costs, and Treatment Implications of Genomic Classifier Testing for Localized Prostate Cancer in the United StatesJames R Janopaul-Naylor, Dattatraya Patil, Shreyas Joshi, et al.
Cancers|December 9, 2023
Integrated Genomic Analysis of Primary Prostate Tumor Foci and Corresponding Lymph Node Metastases Identifies Mutations and Pathways Associated with MetastasisCarlos S Moreno, Cynthia L Winham, Mehrdad Alemozaffar, et al.
Cancer Biomarkers : Section a of Disease Markers|March 20, 2025
A simplified MyProstateScore2.0 for high-grade prostate cancerTiffany M Tang, Yuping Zhang, Ana M Kenney, et al.
Urology|March 12, 2026
Patient-reported psychological and prostate cancer-specific functional outcomes among men with low-risk prostate cancer two years after diagnosis: The PREPARE prospective cohort studyKimberly M Davis, George Luta, Richard M Hoffman, et al.
Pageof 18